SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
about
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationImmune responses to human cancer stem-like cells/cancer-initiating cellsAccumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody.Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivoTrial watch: Naked and vectored DNA-based anticancer vaccinesProspective analysis of antigen-specific immunity, stem-cell antigens, and immune checkpoints in monoclonal gammopathy.Sex-determining region of Y chromosome-related high-mobility-group box 2 in malignant tumors: current opinions and anticancer therapy.Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC.Harnessing shared antigens and T-cell receptors in cancer: Opportunities and challengesCobalt and nickel stabilize stem cell transcription factor OCT4 through modulating its sumoylation and ubiquitination.Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma.Targeting human dendritic cells in situ to improve vaccines.SOX2 and cancer: current research and its implications in the clinicThe non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcomeImmunotherapy and lung cancer: current developments and novel targeted therapies.SOX2 immunity and tissue resident memory in children and young adults with glioma.Recent advances and new opportunities for targeting human dendritic cells in situ.Radiation and Anti-Cancer Vaccines: A Winning Combination.Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
P2860
Q26745972-1C41C4DB-0790-4C90-B1BA-61D2B2591977Q26781794-7E7BAF30-852F-4C73-A780-1B921FF568CBQ35036388-9ED6DCAD-6223-413A-BDC6-EE5EEDC17315Q35235365-CBB67BA5-59D4-4560-BCFB-DEAE02EA622EQ35798986-B77F8F7A-9C75-4B4D-ADCC-1C6E0DF5A2D6Q36322760-71249123-ECC7-4EEC-AA76-62E1DA02F0BFQ36816445-D6336273-12BF-4650-B3D3-361FFCC970EFQ36821101-EFD7A89B-6D09-437D-A974-14122106006AQ37126636-61BA6E4E-3C1C-4D19-BAC2-109141C37C02Q37538184-7E963633-5CA3-4771-9700-0809A6A85107Q37660428-7D42F633-18E1-469F-A408-23CF6D0DEDFAQ38235001-0F239143-51D0-48E0-8BE5-3442E77D210CQ38239137-E1A722A2-8DA8-4050-946F-89392EA5E3D0Q38264982-0172D184-6253-4842-BBA8-7339E8F2D22AQ38286376-E6BB477D-1F6A-4A61-B4DE-E4FE7CED3490Q38373829-6E429F33-E633-414A-A3ED-EE48A38D119DQ43104025-DA276812-FE37-4EDA-B6EC-022B81F0B936Q47547584-E607E101-56DB-4690-B345-9D231503EFFFQ50457532-B80E2386-1674-4788-80E3-DC75D3B4ED3EQ54945263-F0E41D60-DC5C-4465-8D05-18E8A195037EQ56890857-674ED224-787C-4714-960F-3F7E595D4584
P2860
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@en
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@nl
type
label
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@en
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@nl
prefLabel
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@en
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@nl
P2093
P2860
P356
P1433
P1476
SOX2-specific adaptive immunit ...... in non-small cell lung cancer
@en
P2093
Henry Zebroski
Kavita M Dhodapkar
Madhav V Dhodapkar
Scott N Gettinger
P2860
P304
P356
10.4161/ONCI.25205
P577
2013-06-10T00:00:00Z